ArticleCureus2026
Evaluation of the Efficacy of Serum Lactate-to-Albumin Ratio as a Prognostic Marker for Sepsis and Its Comparison With the Sequential Organ Failure Assessment (SOFA) Score.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSepsis is a condition resulting from an abnormal host response to infection that leads to acute organ dysfunction. Early identification of patients at high risk of adverse outcomes is essential. This study aimed to evaluate the prognostic value of the serum lactate-to-albumin (L/A) ratio for sepsis and compare its performance with the Sequential Organ Failure Assessment (SOFA) score in predicting clinical outcomes. MATERIALS AND
methodsThis prospective observational study was conducted at a tertiary care centre from June 2024 to December 2025 and included 90 adult patients diagnosed with sepsis. Serum lactate, serum albumin, and the SOFA scores were recorded on day one and day three. Patients were followed until discharge or in-hospital death. The primary endpoint was in-hospital mortality, while secondary endpoints included the requirement for mechanical ventilation, the need for vasopressor therapy, and length of hospital stay. Statistical analysis was performed using SPSS Statistics version 26 (IBM Corp., Armonk, NY, USA). Continuous variables were expressed as mean ± standard deviation and compared using the Mann-Whitney U test or the Wilcoxon signed-rank test, while categorical variables were analysed using the chi-square test. Receiver operating characteristic (ROC) curve analysis was performed to evaluate predictive ability.
resultsMortality was seen in 42 (46.7%) patients, with a predominance of those aged 61 to 80 years (41, 45.6%) and of the male gender (55, 61.1%). Non-survivors had significantly higher SOFA scores. While the baseline L/A ratio was not significant (p = 0.625), the day three L/A ratio and its change were significantly higher in non-survivors (p < 0.001). On day three, 33 (36.7%) patients required mechanical ventilation and 40 (44.5%) required vasopressors; higher L/A ratios were significantly associated with these outcomes (p ≤ 0.001). The ROC analysis showed strong predictive ability for SOFA day three (area under the curve (AUC) 0.907) and good performance for L/A day three (AUC 0.813).
conclusionSerial measurement of the L/A ratio provides meaningful prognostic information comparable to the SOFA score and may serve as a practical risk stratification tool for sepsis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.